-
Loading metrics
Open Access
Peer-reviewed
Research Article
Tumor Site Immune Markers Associated with Risk for Subsequent Basal Cell Carcinomas
-
Ronald Glaser ,
* E-mail: Ronald.glaser@osumc.edu
Affiliations Institute for Behavioral Medicine Research, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
Rebecca Andridge,
Affiliation Division of Biostatistics, The Ohio State University College of Public Health, Columbus, Ohio, United States of America
⨯ -
Eric V. Yang,
Affiliations Institute for Behavioral Medicine Research, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University Medical Center, Columbus, Ohio, United States of America,
⨯ -
Arwa Y. Shana'ah,
Affiliation Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
Michael Di Gregorio,
Affiliation Institute for Behavioral Medicine Research, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
Min Chen,
Affiliation Institute for Behavioral Medicine Research, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
Sheri L. Johnson,
Affiliation Department of Psychology, University of California, Berkeley, Berkeley, California, United States of America
⨯ -
Lawrence A. De Renne,
Affiliation Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
David R. Lambert,
Affiliations Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Division of Dermatology, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
Scott D. Jewell,
Affiliation Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
Mark A. Bechtel,
Affiliations Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Division of Dermatology, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
Dean W. Hearne,
Affiliations Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Division of Dermatology, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
Joel Bain Herron,
Affiliations Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Division of Dermatology, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯ -
Janice K. Kiecolt-Glaser
Affiliations Institute for Behavioral Medicine Research, The Ohio State University Medical Center, Columbus, Ohio, United States of America, Department of Psychiatry, The Ohio State University Medical Center, Columbus, Ohio, United States of America
⨯
Tumor Site Immune Markers Associated with Risk for Subsequent Basal Cell Carcinomas
- Ronald Glaser,
- Rebecca Andridge,
- Eric V. Yang,
- Arwa Y. Shana'ah,
- Michael Di Gregorio,
- Min Chen,
- Sheri L. Johnson,
- Lawrence A. De Renne,
- David R. Lambert,
- Scott D. Jewell
- Published: September 29, 2011
- https://doi.org/10.1371/journal.pone.0025160